Results 221 to 230 of about 240,433 (353)

480MO Prevalence and characteristics of TP53 Y220C mutations in patients with solid malignancies [PDF]

Yostena Mekhail
openalex   +1 more source

Cytoreductive Surgery in Patients With Metastatic Succinate Dehydrogenase‐Deficient Gastrointestinal Stromal Tumors

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Succinate dehydrogenase‐deficient (SDH‐deficient) gastrointestinal stromal tumors (GIST) are characterized by variable disease biology with poor responses to traditional tyrosine kinase inhibitors. The role of surgical intervention has been highly debated.
Katherine Y. Chen, Mark Antkowiak, Ashwyn K. Sharma, Robert Mallory, Adam M. Burgoyne, Paul T. Fanta, Jason K. Sicklick   +6 more
wiley   +1 more source

CF10 Displays Improved Synergy with Oxaliplatin in <i>TP53</i>-Null and Wild-Type CRC Cells from Increased Top1cc and Replication Stress. [PDF]

Cancers (Basel)
Young TM, Moumouni R, Behl A, Das U, Gmeiner WH.   +4 more
europepmc   +1 more source

EP.11C.04 Retrospective Evaluation of Biomarkers (KRAS, TP53, STK11, KEAP1, POLE, PIK3CA, ARID1A) In Patients with NSCLC IV [PDF]

J. Roeper, Martin Falk, Stefanie Schatz, Lukas C. Heukamp, F. Griesinger   +4 more
openalex   +1 more source

TP53 CpG Site Mutations Predict the Survival of First-Line Chemoimmunotherapy in Advanced Lung Adenocarcinoma. [PDF]

Thorac Cancer
Wu L, Zou Z, Li Y, Hao X, Zhang J, Ying J, Xing P, Li J.   +7 more
europepmc   +1 more source

Heterogeneous TP53 mutation subtypes define prognostic classification in Mantle Cell Lymphoma [PDF]

Shuozi Liu, Ping Yang, Shaowei Zhou, Weilong Zhang, Jing Wang, Lingli Wang, Chunyuan Li, Yingtong Chen, Wenxin Qi, Hongmei Jing   +9 more
openalex   +1 more source

TP53 NP_000537.3:p.G245S [PDF]

, 2020
openaire   +1 more source

Exome Sequencing Identifies Variants in MLH1 and ERBB2 as Potential Cancer‐Predisposing Factors in Familial Early‐Onset Colorectal Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Colorectal cancer (CRC) has raised considerable health concerns worldwide, with increasing incidence rates, specifically among younger populations. Despite remarkable progress in diagnosing and treating various diseases, the genetic basis of CRC remains only partially understood.
Behnaz Bagheri, Neda Mohsen‐Pour, Najmeh Salehi, Pardis Ketabi Moghadam, Adel Zeinalpour, Amir Sadeghi, Samira Kalayinia, Nayeralsadat Fatemi   +7 more
wiley   +1 more source

Mechanistic overview and suggested strategies to overcome BCL-2 inhibitor resistance in <i>TP53-</i>mutated acute myeloid leukemia. [PDF]

Front Cell Dev Biol
Iqbal U, Shallis RM.
europepmc   +1 more source

Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience

, 2015
Sameh Gaballa, Rima M. Saliba, Jonathan E. Brammer, Gary Lu, Nina Shah, Qaiser Bashir, Simrit Parmar, Fabian Bock, Chitra Hosing, Uday Popat, Ruby Delgado, Gabriela Rondón, Jatin J. Shah, Elisabet E. Manasanch, Robert Z. Orlowski, Richard E. Champlin, Muzaffar H. Qazilbash   +16 more
openalex   +1 more source